Paul M Palevsky

University Of Pittsburgh At Pittsburgh

$1,874,040

Attributed

$6,689,364

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY2013–25

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,689,364 · 4

By mechanism

U01$4,268,975 · 1

UH3$900,000 · 1

R01$773,226 · 1

UG3$747,163 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

John A Kellum$12,228,358
Henry E Wang$15,583,055
Sachin Yende$4,689,239
David J Hackam$18,393,277
Kaleab Z Abebe$3,977,374

Others in their field

Top investigators on “Cessation Of Life”

David R. Weir · University Of Michigan At Ann Arbor$345,522,974
John M Lachin · George Washington University$134,302,892
David M Nathan · Massachusetts Institute Of Technology$127,791,564
Judith S Hochman · New York University School Of Medicine$112,898,313
Jeffrey H Samet · Boston University Medical Campus$91,739,367
Judith S. Currier · University Of California Los Angeles$85,330,415

Research focus

Cessation Of LifeCollaborationsAcuteProgramsUniversitiesIncidenceHigh RiskChronic Kidney FailureSyndromeProceduresProtocols DocumentationAcute Renal Failure With Renal Papillary NecrosisMedicalHospitalsKidneyInjury To KidneyFollow-UpEnd Stage Renal FailureGlucoseData ManagementClinical CenterDesignHealth Related Quality Of LifeCaring